Correlation Between Viracta Therapeutics and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Pulmatrix, you can compare the effects of market volatilities on Viracta Therapeutics and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Pulmatrix.
Diversification Opportunities for Viracta Therapeutics and Pulmatrix
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viracta and Pulmatrix is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Pulmatrix go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Pulmatrix
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Pulmatrix. In addition to that, Viracta Therapeutics is 1.2 times more volatile than Pulmatrix. It trades about -0.05 of its total potential returns per unit of risk. Pulmatrix is currently generating about 0.05 per unit of volatility. If you would invest 379.00 in Pulmatrix on November 2, 2024 and sell it today you would earn a total of 388.00 from holding Pulmatrix or generate 102.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Pulmatrix
Performance |
| Timeline |
| Viracta Therapeutics |
| Pulmatrix |
Viracta Therapeutics and Pulmatrix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Pulmatrix
The main advantage of trading using opposite Viracta Therapeutics and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |